Well, maybe the trial has in fact been accelerated then. The timeline chart from the Sept. 15 PR lists the interim in 1H 2017 and final data in 2H 2017. So I will venture a guess that yesterdays PR just updated that timeline to let us know that the trial is to be COMPLETE and we get interim data in the same span in 2Q17. That seems like a positive to me.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links